Curanex Pharmaceuticals (CURX) Interest Coverage Ratio (2024 - 2025)

Curanex Pharmaceuticals' (CURX) quarterly Interest Coverage Ratio came in at 3.93 in Q3 2025, down 1070.71% on a QoQ basis from 0.34 in Q2 2025.

Curanex Pharmaceuticals (CURX) Interest Coverage Ratio (2024 - 2025) Analysis & Trends

Curanex Pharmaceuticals (CURX) has 2 years of Interest Coverage Ratio data on file, last reported at 3.93 in Q3 2025.

Quarterly Interest Coverage Ratio changed N/A year-over-year to 3.93 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 5.17 (changed N/A YoY) and the FY2025 annual result came in at 4.17, down 48.48% from the prior year.
Interest Coverage Ratio eased to 3.93 in Q3 2025, from 0.34 in the prior quarter.
In the past five years, Interest Coverage Ratio ranged from a high of 0.34 in Q2 2025 to a low of 3.93 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Interest Cover (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	117.59
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	8.18
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	2.82
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-0.08
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	1.42
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	76.86
10	Curanex Pharmaceuticals	6.11 Mn	1.11 Mn	-	-

Download Data